Finnrick, an independent testing programme, publishes 5 assays for Shandong Nuoweiou Medical Technology Co: 4 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 1 did not. Most recent assay 9 Oct 2025.
Shandong Nuoweiou Medical Technology Co operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/shandong-nuoweiou-medical-technology-co.
Finnrick-tested with good results. Tested across 1 peptide products with 5 total samples.
Shandong Nuoweiou Medical Technology Co is listed as active. Finnrick Grade B. Finnrick avg score: 6.4/10 across 5 samples (1 products). Good quality with consistent test results.
Shandong Nuoweiou Medical Technology Co holds independent lab grade B, assigned across 5 graded samples, average score 6.4/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Shandong Nuoweiou Medical Technology Co, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 5 | 4 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | B (5 samples) |
| Average grader score | 6.4/10 |
| Vendor type | Research-use supplier |
Shandong Nuoweiou Medical Technology Co is listed as active and we hold 5 Finnrick assays (4 passing, 1 failing its purity threshold); an independent lab grade of B. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 5 assays for Shandong Nuoweiou Medical Technology Co: 4 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 1 did not. Most recent assay 9 Oct 2025.
Similar vendors: Amino Asylum, Guangzhou Jeep Biotechnology JEEP, Noble Dragons, Peptide Partners, Lipeptides, Zhengzhou Lanyun, Orbitrex Peptides, Peptide Technologies.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Shandong Shengyuan Peptide Technology Review, Shandong Zhongle Peptides Review, Shanghai Angel Chemical ASC Peptides Review.